TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Europe T Cell Therapy Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe T Cell Therapy Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Growing Burden of Cancer Worldwide
4.1.2 Increasing Number of T-Cell Therapy Approvals
4.2 Market Restraints
4.2.1 Side-effects of CAR T-Cell Therapy
4.3 Market Opportunities
4.3.1 Growing Investment in T-Cell Therapy
4.4 Future Trends
4.4.1 Rising Number of CAR T-Cell Therapies in Clinical Trials
4.5 Impact Analysis:
5. T Cell Therapy Market - Europe Market Analysis
5.1 Europe T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
6. Europe T Cell Therapy Market - Revenue and Forecast to 2030 - by Modality.
6.1 Overview
6.2 Europe T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
6.3 Research
6.3.1 Overview
6.3.2 Research: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Commercialized
6.4.1 Overview
6.4.2 Commercialized: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe T Cell Therapy Market - Revenue and Forecast to 2030 - by Therapy Type
7.1 Overview
7.2 Europe T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
7.3 CAR T-cell Therapy
7.3.1 Overview
7.3.2 CAR T-cell Therapy: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 T-cell Receptor (TCR)-based.
7.4.1 Overview
7.4.2 T-cell Receptor (TCR)-based: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe T Cell Therapy Market - Revenue and Forecast to 2030 - by Indication
8.1 Overview
8.2 Europe T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
8.3 Hematologic Malignancies
8.3.1 Overview
8.3.2 Hematologic Malignancies: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3.3 Europe T Cell Therapy Market, by Haematological Malignancies, 2020-2030 (US$ Million)
8.4 Solid Tumor
8.4.1 Overview
8.4.2 Solid Tumor: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe T Cell Therapy Market - Country Analysis
9.1 Europe
9.1.1.1 Europe T Cell Therapy Market, by Country
9.1.1.2 UK
9.1.1.2.1 UK Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.2 UK: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.2.3 UK: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.2.4 UK: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.2.4.1 UK: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.3 Germany
9.1.1.3.1 Germany: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 Germany: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.3.3 Germany: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.3.4 Germany: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.3.4.1 Germany: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.4 France
9.1.1.4.1 France: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.2 France: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.4.3 France: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.4.4 France: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.4.4.1 France: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.5 Italy
9.1.1.5.1 Italy: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 Italy: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.5.3 Italy: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.5.4 Italy: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.5.4.1 Italy: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.6 Spain
9.1.1.6.1 Spain: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.6.2 Spain: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.6.3 Spain: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.6.4 Spain: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.6.4.1 Spain: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.7 Rest of Europe
9.1.1.7.1 Rest of Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 Rest of Europe: Europe T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.7.3 Rest of Europe: Europe T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.7.4 Rest of Europe: Europe T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.7.4.1 Rest of Europe: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
10. T Cell Therapy Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in T Cell Therapy Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Immunocore Holdings Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Legend Biotech Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Janssen Global Services LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Gilead Sciences Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Novartis AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Innovent Biologics Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms



List of Tables
Table 1. Europe T Cell Therapy Market Segmentation
Table 2. Europe T Cell Therapy Market, by Hematological Malignancies - Revenue and Forecast to 2030 (US$ Million)
Table 3. UK Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany: Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany: Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 11. France: Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 12. France: Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. France: Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Spain: Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Europe T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 27. Recent Organic Growth Strategies in Europe T Cell Therapy Market
Table 28. Recent Inorganic Growth Strategies in the Europe T Cell Therapy Market
Table 29. Glossary of Terms, Europe T Cell Therapy Market

List of Figures
Figure 1. Europe T Cell Therapy Market Segmentation, By Country
Figure 2. Europe T Cell Therapy Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
Figure 6. Research: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Commercialized: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
Figure 9. CAR T-cell Therapy: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. T-cell Receptor (TCR)-based: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
Figure 12. Hematologic Malignancies: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solid Tumor: Europe T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe T Cell Therapy Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 15. Europe T Cell Therapy Market, By Key Countries, 2022 and 2030 (%)
Figure 16. UK Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Germany: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. France: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Italy: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. Spain: Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Rest of Europe T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Growth Strategies in T Cell Therapy Market


CONTACT US

If you have any queries about this report or would like further information, please contact us:

US: +1-646-491-9876
Asia-Pacific: +91-20-69018686
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com




DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, \"The Insight Partners\".